- Home
- SOTK vs MAIA Comparison
SOTK vs MAIA Comparison
Compare SOTK & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- MAIA
- Stock Information
- Founded
- SOTK 1975
- MAIA 2018
- Country
- SOTK United States
- MAIA United States
- Employees
- SOTK N/A
- MAIA N/A
- Industry
- SOTK Industrial Machinery/Components
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- MAIA Health Care
- Exchange
- SOTK Nasdaq
- MAIA Nasdaq
- Market Cap
- SOTK 60.5M
- MAIA 46.7M
- IPO Year
- SOTK 1987
- MAIA 2022
- Fundamental
- Price
- SOTK $3.98
- MAIA $1.96
- Analyst Decision
- SOTK Buy
- MAIA
- Analyst Count
- SOTK 1
- MAIA 0
- Target Price
- SOTK $7.50
- MAIA N/A
- AVG Volume (30 Days)
- SOTK 9.1K
- MAIA 319.8K
- Earning Date
- SOTK 05-22-2025
- MAIA 05-20-2025
- Dividend Yield
- SOTK N/A
- MAIA N/A
- EPS Growth
- SOTK N/A
- MAIA N/A
- EPS
- SOTK 0.07
- MAIA N/A
- Revenue
- SOTK $20,151,145.00
- MAIA N/A
- Revenue This Year
- SOTK $6.11
- MAIA N/A
- Revenue Next Year
- SOTK $9.27
- MAIA N/A
- P/E Ratio
- SOTK $57.15
- MAIA N/A
- Revenue Growth
- SOTK 8.40
- MAIA N/A
- 52 Week Low
- SOTK $3.50
- MAIA $1.40
- 52 Week High
- SOTK $6.05
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- SOTK 58.99
- MAIA 52.24
- Support Level
- SOTK $3.75
- MAIA $1.80
- Resistance Level
- SOTK $4.07
- MAIA $2.18
- Average True Range (ATR)
- SOTK 0.21
- MAIA 0.31
- MACD
- SOTK 0.01
- MAIA -0.01
- Stochastic Oscillator
- SOTK 45.79
- MAIA 35.00
About SOTK Sono-Tek Corporation
Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.